System C's New Product to Protect Sensitive Healthcare Data

System CSystem C has announced the launch of a new product which allows healthcare providers to ensure they are in control of the flow of sensitive personal information and patient health records. Called IGFlow, the new product will be showcased for the first time this week at Smart Healthcare (Earls Court, June 9th/10th) and the NHS Confederation annual conference (Liverpool ACC, June 10th-12th).

NHS trusts across Kent have already chosen to implement IGFlow. Morfydd Williams, Programme Director at Kent and Medway Programme Office, praised the product for its ease of use and for the fact that it runs on a modern .NET platform.

"It will allow our trusts to make accessible to all staff the approved methods of sending and receiving personal information as well as an easy method for the Caldicott Guardians to review and update information flows," she said.

In the wake of several high-profile national incidents, NHS chief executive David Nicholson has instructed all trust chief executives to review and tighten their information governance and data transfer arrangements.

IGFlow allows staff to map the flows of 'person identifiable data' (PID) around their own organisation and across to other organisations. It covers email traffic, letters, faxes, CDs tapes, x-rays, and other media. The product includes an automatic risk calculator which analyses and assesses the risk attached to each flow.

"This tool will allow staff to access the information they need in order to send patient identifiable data safely by using trust approved information flows," Ms Williams explained.

Related news articles:

About System C Healthcare plc
System C Healthcare plc (www.systemc.com), specialises in the design and development of clinical patient management and business intelligence software, and provides systems implementation and consulting services to the health sector.

IGFlow was developed by the Bluestar Systems Ltd, the specialist developer and supplier of healthcare IT solutions which was acquired by System C in April this year. Other Bluestar products include the Pathfinder Radio-Frequency ID (RFID) system for tracking patients and equipment.

System C Healthcare is quoted on the London Stock Exchange's Alternative Investment Market.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...